GLUE Stock-Based Compensation
Monte Rosa Therapeutics Inc · Stock-Based Compensation
GLUE Stock-Based Compensation
Latest reported$20.59Mperiod ending
GLUE TTM Stock-Based Comp ($354.00K → $20.59M)
TTM stock-based compensation
High-resolution chart · PNG
GLUE stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 20,592,000 | |
| 19,516,000 | |
| 18,865,000 | |
| 19,025,000 | |
| 18,943,000 | |
| 18,551,000 | |
| 18,126,000 | |
| 17,731,000 | |
| 17,917,000 | |
| 17,568,000 | |
| 16,669,000 | |
| 15,921,000 | |
| 14,667,000 | |
| 13,387,000 | |
| 11,664,000 | |
| 10,194,000 | |
| 9,053,000 | |
| 7,199,000 | |
| 5,200,000 | |
| 3,545,000 | |
| 1,517,000 | |
| 595,000 | |
| 354,000 |